Celularity (NASDAQ:CELU) Stock, Quote.Headers.trade-ideas

Celularity

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Earnings

News

Penny Stocks

Pre-Market Outlook

Markets

Trading Ideas

CELU

WDAY

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Workday, Domino&#39;s And 3 Stocks To Watch Heading Into Monday

Eurozone

Commodities

Small Cap

Global

Intraday Update

CMPR

NRBO

PTON

REVB

VLCN

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday.

The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&amp;P 500 also rose, gaining, 0.87% to 4,887.70.

Dow Jumps 250 Points; Honeywell Issues Weak Forecast

Movers

ALGM

ASST

BFRG

BOOT

BRTX

CACC

CHRW

CMAX

CMND

CTVA

DGII

EGHT

ELAB

ELWS

ETSY

EVAX

EVER

FBLG

FCEL

HSAI

IFBD

Kiora Pharmaceuticals, Inc. - Common Stock

KPRX

MINM

NVIV

NYCB

OGEN

PLUG

PSNY

RACE

RKLB

SPWR

SRDX

TCRT

WOLF

YOSH

ZION

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Press Releases

Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company

Health Care

Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products

Analyst Ratings

Celularity Announces Publication of "Senescence, NK cells, and cancer: navigating the crossroads of aging and disease" in the April 4, 2025, Issue of Frontiers in Immunology

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products

Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees

Celularity Announces Full Year 2024 Operating and Financial Results

Celularity Receives Nasdaq Notice Regarding Form 10-Q

Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology

Management

Celularity Announces Chief Financial Officer Transition

Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies

CELUW

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Aligos Therapeutics

Annovis Bio

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Gain Therapeutics

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

PepGen

Pluri

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Shattuck Labs

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

Exicure

Xilio Therapeutics

Morgan Stanley

HC Wainwright & Co.

Alliance Global Partners

Truist Securities

Comments

Celularity

Celularity (NASDAQ:CELU) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell